Transcript
Modern CAR-T workflows depend on CD19 that preserves its native ectodomain structure and has reliable high-affinity binding.
- CAR expression detection
- scFv generation and screening
- CAR-T development assays
Conigen’s mammalian-expressed CD19 dimers use a short, proprietary linker to stabilize the cis-dimer ectodomain driving superior binding affinity and a wider assay window.
These Fc-free, high-fidelity dimers outperform monomers and are available in human, mouse, and non-human primate versions, including biotinylated Avi-tag and custom variants. Start your next discovery with Conigen’s CD19.